Issues relating to lymphovascular invasion in breast carcinoma

被引:30
|
作者
Hoda, Syed A.
Hoda, Rana S.
Merlin, Scott
Shamonki, Jamie
Rivera, Michael
机构
[1] Cornell Univ, Dept Pathol, New York Presbyterian Hosp, Weill Cornell Ctr,Weill Med Coll, New York, NY 10021 USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
关键词
breast; breast carcinoma; diagnosis; lymphovascular invasion; tumor emboli; vascular invasion;
D O I
10.1097/01.pap.0000213048.69564.26
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Lymphovascular invasion (LVI) by tumor cells is histologically evident in approximately 15% of invasive mammary duct carcinomas and is present in approximately 10% of cases with pathologically negative lymph nodes. LVI is indicative of unfavorable prognosis in the breast cancer-as manifested by increased local failure and reduced overall survival. It is for this reason that LVI is routinely included in the evaluation and reporting of all breast cancers. There are a variety of interpretative difficulties in the histopathologic assessment of LVI, and the clinical implications of any misinterpretation can be profound. This brief review seeks to highlight the difficulties in the evaluation of LVI in breast cancer.
引用
收藏
页码:308 / 315
页数:8
相关论文
共 50 条
  • [11] Morphologic Features and Prognostic Value of Lymphovascular Invasion in Lymph Node Positive Breast Carcinoma
    Hilliges, C.
    Hsu, M.
    Gallagher, M.
    Stempel, M.
    El-Tamer, M.
    Brogi, E.
    MODERN PATHOLOGY, 2014, 27 : 54A - 54A
  • [12] Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma
    Anne-Sophie Hamy
    Giang-Thanh Lam
    Enora Laas
    Lauren Darrigues
    Thomas Balezeau
    Julien Guerin
    Alain Livartowski
    Benjamin Sadacca
    Jean-Yves Pierga
    Anne Vincent-Salomon
    Florence Coussy
    Veronique Becette
    Hélène Bonsang-Kitzis
    Roman Rouzier
    Jean-Guillaume Feron
    Gabriel Benchimol
    Marick Laé
    Fabien Reyal
    Breast Cancer Research and Treatment, 2018, 169 : 295 - 304
  • [13] Clinicopathological Significance of Lymphovascular Invasion in Urothelial Carcinoma
    Mazzucchelli, Roberta
    Cheng, Liang
    Lopez-Beltran, Antonio
    Scarpelli, Marina
    Montironi, Rodolfo
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2012, 34 (04): : 173 - 179
  • [14] The impact of lymphovascular invasion on survival in oral carcinoma
    Jones, H. B.
    Sykes, A.
    Bayman, N.
    Sloan, P.
    Swindel, R.
    Patel, M.
    Musgrove, B.
    ORAL ONCOLOGY, 2009, 45 (01) : 10 - 15
  • [15] Calpastatin is associated with lymphovascular invasion in breast cancer
    Storr, Sarah J.
    Mohammed, Rabab A. A.
    Woolston, Caroline M.
    Green, Andrew R.
    Parr, Tim
    Spiteri, Inmaculada
    Caldas, Carlos
    Ball, Graham R.
    Ellis, Ian O.
    Martin, Stewart G.
    BREAST, 2011, 20 (05): : 413 - 418
  • [16] Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma
    Lee, AHS
    Pinder, SE
    Macmillan, RD
    Mitchell, M
    Ellis, IO
    Elston, CW
    Blamey, RW
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (03) : 357 - 362
  • [17] Telomerase activity and lymphovascular invasion in breast cancer
    Mokbel, KM
    Parris, CN
    Ghilchik, M
    Amerasinghe, CN
    Newbold, RF
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (01): : 30 - 33
  • [18] Identification of lymphovascular invasion in breast biopsy specimens
    van la Parra, R.
    Mulder, D.
    Ernst, M. F.
    De Roos, W. K.
    Bosscha, K.
    EJC SUPPLEMENTS, 2010, 8 (03): : 93 - 93
  • [19] Lymphovascular Invasion in Cutaneous Squamous Cell Carcinoma
    Ryan, Michael P.
    Winsett, Frank T.
    Armenta, Andrew M.
    Goodwin, Brandon P.
    Wagner Jr, Richard F.
    DERMATOLOGIC SURGERY, 2024, 50 (08) : 699 - 704
  • [20] Are Perineural Invasion and Lymphovascular Invasion Significant Predictors of Breast Cancer Outcomes?
    Paul, Dale
    Belay, Claire
    Scott, Anthony
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S245 - S246